JPMHC 2020

#JPM20: Vertex lays out post-CF ambitions as Gilead demurs on acquisition
Endpoints
Mon, 01/13/20 - 11:53 pm
Vertex Pharmaceuticals
cystic fibrosis
JPMHC 2020
Gilead Sciences
M&A
JPM: With new ethics plan, Novartis chief puts his money where his mouth is
Fierce Pharma
Mon, 01/13/20 - 11:45 pm
Novartis
ethics
Pharma CEOs
Vas Narasimhan
JPMHC 2020
JPM: Bristol chief says one-third of Celgene cost cuts will hit in 2020
Fierce Pharma
Mon, 01/13/20 - 11:43 pm
M&A
JPMHC 2020
Bristol-Myers Squibb
Celgene
Giovanni Caforio
JP Morgan Preview: Small, Medium and Large, with a Lot of M&A Speculation
BioSpace
Mon, 01/13/20 - 11:08 am
JPMHC 2020
M&A
Exelixis
Intercept Pharmaceuticals
Avidity Biosciences
Theravance
Moderna Therapeutics
Kodiak Sciences
No sleep, exiled mattresses, cleared bank accounts: Getting deals done at JPM
Fierce Biotech
Mon, 01/13/20 - 11:05 am
JPMHC 2020
M&A
Flannel Is the New Black at the 2020 J.P. Morgan Healthcare Conference
Observer
Mon, 01/13/20 - 10:57 am
JPMHC 2020
flyover tech
digital technology
Charles River pens Takeda early-stage drugs deal
Fierce Biotech
Mon, 01/13/20 - 10:53 am
JPMHC 2020
Charles River Laboratories
Takeda
A Preview Of JPMorgan's Healthcare Conference: Focus On Value-Creating Themes, 2020 Expectations
Yahoo/Benzinga
Sat, 01/11/20 - 11:02 pm
JPMHC 2020
Bristol-Myers Squibb
Vertex Pharmaceuticals
Biomarin
Regeneron
Biogen
Alexion
Gilead Sciences
Amgen
5 biotech trends to follow in 2020
BioPharma Dive
Sat, 01/11/20 - 12:03 am
biotech
M&A
drug launches
JPMHC 2020
The ghosts of JPMs past: How 20 years of deals, scandal, and science have shaped health care
Stat
Thu, 01/9/20 - 03:53 pm
JPMHC 2020
JPMorgan
Will Clovis’ Rubraca sales shortfall revive talk of a buyout at JP Morgan?
Fierce Pharma
Wed, 01/8/20 - 12:09 pm
Clovis Oncology
Rubraca
M&A
JPMHC 2020
Fear and loathing in Union Square: Upcoming biotech conference exposes industry dreams, issues
Bizjournals
Mon, 01/6/20 - 10:21 am
JPMHC 2020
San Francisco
biotech
Biotech execs predict big M&A deals ahead as mood shifts in wake of a 2018 hangover — Endpoints 100
Endpoints
Tue, 03/12/19 - 11:59 am
JPMHC 2020
biotech
drug pricing
M&A

Pages